Your browser doesn't support javascript.
loading
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
Hörsch, Dieter; Anthony, Lowell; Gross, David J; Valle, Juan W; Welin, Staffan; Benavent, Marta; Caplin, Martyn; Pavel, Marianne; Bergsland, Emily; Öberg, Kjell; Kassler-Taub, Kenneth B; Binder, Polina; Banks, Phillip; Lapuerta, Pablo; Kulke, Matthew H.
Afiliação
  • Hörsch D; Department of Gastroenterology/Endocrinology, Center for Neuroendocrine Tumors, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Anthony L; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
  • Gross DJ; Neuroendocrine Tumor Unit, Department of Medicine, Endocrine Service, European Neuroendocrine Tumor Society Center of Excellence, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Valle JW; University of Manchester/The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Welin S; Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.
  • Benavent M; Medical Oncology Department, Virgen del Rocío University Hospital/Instituto de Biomedicina de Sevilla, Seville, Spain.
  • Caplin M; Department of Gastroenterology & Hepatobiliary Medicine, Royal Free Hospital, Pond Street Centre for Gastroenterology, London, United Kingdom.
  • Pavel M; Department of Gastroenterology and Hepatology, Charité-Universitätsmedizin, Berlin, Germany.
  • Bergsland E; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California, USA.
  • Öberg K; Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.
  • Kassler-Taub KB; Lexicon Pharmaceuticals, Inc., The Woodlands, Texas, USA.
  • Binder P; Lexicon Pharmaceuticals, Inc., The Woodlands, Texas, USA.
  • Banks P; Lexicon Pharmaceuticals, Inc., The Woodlands, Texas, USA.
  • Lapuerta P; Lexicon Pharmaceuticals, Inc., The Woodlands, Texas, USA.
  • Kulke MH; Section of Hematology/Oncology, Boston University and Boston Medical Center, Boston, Massachusetts, USA.
Neuroendocrinology ; 112(3): 298-310, 2022.
Article em En | MEDLINE | ID: mdl-33940581
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndrome do Carcinoide Maligno Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Humans Idioma: En Revista: Neuroendocrinology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndrome do Carcinoide Maligno Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Humans Idioma: En Revista: Neuroendocrinology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha